Sabra Health Care REIT (SBRA) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

SBRA Stock Forecast


Sabra Health Care REIT (SBRA) stock forecast, based on 29 Wall Street analysts, predicts a 12-month average price target of $21.33, with a high of $22.00 and a low of $21.00. This represents a 2.01% increase from the last price of $20.91.

$13 $14 $15 $16 $17 $18 $19 $20 $21 $22 High: $22 Avg: $21.33 Low: $21 Last Closed Price: $20.91

SBRA Stock Rating


Sabra Health Care REIT stock's rating consensus is Hold, based on 29 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 11 Buy (37.93%), 16 Hold (55.17%), 2 Sell (6.90%), and 0 Strong Sell (0.00%).

Hold
Total 29 0 2 16 11 Strong Sell Sell Hold Buy Strong Buy

SBRA Price Target Upside V Benchmarks


TypeNameUpside
StockSabra Health Care REIT2.01%
SectorReal Estate Stocks 10.75%
IndustryHealthcare REIT Stocks3.05%

Price Target Trends


1M3M12M
# Anlaysts139
Avg Price Target$21.00$21.00$20.89
Last Closing Price$20.91$20.91$20.91
Upside/Downside0.43%0.43%-0.10%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26158--14
Feb, 26158--14
Jan, 26159--15
Dec, 25159--15
Nov, 25158--14
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 19, 2026Michael GoldsmithUBS$21.00$20.243.75%0.43%
Feb 17, 2026Richard AndersonCantor Fitzgerald$21.00$20.174.12%0.43%
Jan 20, 2026Michael LewisTruist Financial$21.00$19.249.15%0.43%
Dec 15, 2025Joe DicksteinJefferies$22.00$19.2014.58%5.21%
Nov 25, 2025Wells Fargo$21.00$18.9410.88%0.43%
Oct 21, 2025Wells Fargo$20.00$18.448.46%-4.35%
Oct 17, 2025National Bank$22.00$18.0421.95%5.21%
Oct 01, 2025Richard AndersonCantor Fitzgerald$20.00$18.647.30%-4.35%
Sep 02, 2025Truist Financial$20.00$19.263.84%-4.35%
Sep 12, 2024Nicholas JosephCitigroup$20.00$18.358.99%-4.35%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Feb 19, 2026UBSNeutralNeutralhold
Feb 18, 2026CitigroupBuyBuyhold
Feb 17, 2026Cantor FitzgeraldNeutralNeutralhold
Dec 15, 2025JefferiesBuyBuyhold
Dec 05, 2025Cantor FitzgeraldNeutralNeutralhold
Nov 25, 2025Wells FargoOverweightOverweighthold
Oct 01, 2025Cantor FitzgeraldNeutralinitialise
Oct 11, 2024ScotiabankSector PerformSector Performhold
Sep 12, 2024CitigroupNeutralBuyupgrade
Aug 26, 2024ScotiabankSector PerformSector Performhold

Financial Forecast


EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.52$-0.34$0.06$0.54$0.64---
Avg Forecast$-0.28$0.14$0.12$0.51$0.70$0.75$0.79-
High Forecast$-0.26$0.15$0.12$0.51$0.72$0.81$0.84-
Low Forecast$-0.29$0.13$0.12$0.49$0.68$0.72$0.74-
Surprise %85.71%-342.86%-50.00%5.88%-8.57%---

Revenue Forecast

$500M $600M $700M $800M $900M $1B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$569.54M$624.81M$647.51M$703.24M$774.63M---
Avg Forecast$581.47M$599.63M$647.02M$686.97M$739.76M$782.38M$866.17M$914.11M
High Forecast$604.60M$629.79M$651.41M$688.31M$756.24M$786.45M$898.19M$958.63M
Low Forecast$549.08M$555.79M$644.70M$685.03M$722.35M$778.30M$834.15M$870.26M
Surprise %-2.05%4.20%0.08%2.37%4.71%---

Net Income Forecast

$-250M $-160M $-70M $20M $110M $200M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-113.26M$-77.61M$13.76M$126.71M$155.61M---
Avg Forecast$-141.10M$-155.95M$13.76M$117.15M$162.57M$185.05M$189.97M-
High Forecast$-94.74M$-105.10M$18.24M$119.22M$166.93M$188.21M$195.55M-
Low Forecast$-187.47M$-206.81M$9.27M$115.08M$158.20M$167.30M$172.44M-
Surprise %-19.73%-50.24%-8.17%-4.28%---

SBRA Forecast FAQ


Is Sabra Health Care REIT stock a buy?

Sabra Health Care REIT stock has a consensus rating of Hold, based on 29 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 11 Buy, 16 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Sabra Health Care REIT is a neutral investment for most analysts.

What is Sabra Health Care REIT's price target?

Sabra Health Care REIT's price target, set by 29 Wall Street analysts, averages $21.33 over the next 12 months. The price target range spans from $21 at the low end to $22 at the high end, suggesting a potential 2.01% change from the previous closing price of $20.91.

How does Sabra Health Care REIT stock forecast compare to its benchmarks?

Sabra Health Care REIT's stock forecast shows a 2.01% upside, underperforming the average forecast for the real estate stocks sector (10.75%) and underperforming the healthcare reit stocks industry (3.05%).

What is the breakdown of analyst ratings for Sabra Health Care REIT over the past three months?

  • March 2026: 7.14% Strong Buy, 35.71% Buy, 57.14% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 7.14% Strong Buy, 35.71% Buy, 57.14% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 6.67% Strong Buy, 33.33% Buy, 60.00% Hold, 0% Sell, 0% Strong Sell.

What is Sabra Health Care REIT’s EPS forecast?

Sabra Health Care REIT's average annual EPS forecast for its fiscal year ending in December 2026 is $0.75, marking a 17.19% increase from the reported $0.64 in 2025. Estimates for the following years are $0.79 in 2027, and $0 in 2028.

What is Sabra Health Care REIT’s revenue forecast?

Sabra Health Care REIT's average annual revenue forecast for its fiscal year ending in December 2026 is $782.38M, reflecting a 1.00% increase from the reported $774.63M in 2025. The forecast for 2027 is $866.17M, and $914.11M for 2028.

What is Sabra Health Care REIT’s net income forecast?

Sabra Health Care REIT's net income forecast for the fiscal year ending in December 2026 stands at $185.05M, representing an 18.92% increase from the reported $155.61M in 2025. Projections indicate $189.97M in 2027, and $0 in 2028.